SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-23-002765
Filing Date
2023-04-28
Accepted
2023-04-28 17:07:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 phio_s1.htm S-1 247796
2 OPINION OF HOGAN LOVELLS US LLP phio_ex0501.htm EX-5.1 7612
3 CONSENT OF BDO USA, LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2489
4 CALCULATION OF FILING FEE TABLES phio_ex107.htm EX-FILING FEES 42114
5 GRAPHIC image_001.jpg GRAPHIC 2554
6 GRAPHIC image_002.jpg GRAPHIC 3048
7 GRAPHIC image_003.jpg GRAPHIC 2231
  Complete submission text file 0001683168-23-002765.txt   312308
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-271521 | Film No.: 23868127
SIC: 2834 Pharmaceutical Preparations